SEACAP: Improving Chronic Pain Treatment in Primary Care

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00129480
Collaborator
(none)
401
1
2
53.9
7.4

Study Details

Study Description

Brief Summary

The primary objective of this study is to determine to what extent a collaborative intervention improves chronic pain-related outcomes in a VA primary care setting. We will also determine to what extent the intervention affects 1) treatment of co-occurring depression, 2) adherence of providers to guidelines for treating chronic pain, and 3) patient and provider satisfaction and attitudes related to chronic pain treatment.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Assistance with Pain treatment
N/A

Detailed Description

Background:

Chronic pain is very common, and associated with substantial impairment and increased healthcare utilization. Implementation of treatment guidelines has been problematic, and chronic pain remains undertreated. Because of the prevalence of chronic pain among veterans, the VHA created a National Pain Management Strategy and adopted pain as the "5th vital sign."

Objectives:

Our primary objective was to determine to what extent a collaborative intervention improves chronic pain-related outcomes (pain-related function, pain severity and depression severity) in a VA primary care setting over six and 12 months. We also investigated to what extent the intervention affected 1) treatment of comorbid depression, 2) adherence of providers to guidelines for chronic pain, 3) patient and provider satisfaction and attitudes related to chronic pain treatment, and 4) incremental benefit (pain disability-free days) and incremental health services costs.

Methods:

The study was a cluster randomized controlled trial of a collaborative care intervention "Assistance with Pain Treatment" (APT) versus treatment as usual (TAU) at five primary care clinics of one Department of Veterans Affairs Medical Center.

401 patients and 42 primary care clinicians participated. APT included a 2-session clinician education program, patient assessment, education and activation, symptom monitoring, feedback and recommendations to clinicians and facilitation of specialty care. We randomized clinicians to APT or TAU, and nested patients within clinician intervention status.

Patients were recruited via mailings and advertising flyers; those with chart-documented musculoskeletal pain diagnoses who reported at least moderate pain severity and pain-related function (Chronic Pain Grade [CPG]) lasting at least 12 weeks were invited to participate. Participants completed questionnaires at baseline, 3, 6 and 12 months, with a subset re-assessed at 30 months. Primary outcomes were Roland-Morris Disability scores and CPG pain intensity scale scores over 12 months. Depression was assessed using Patient Health Questionnaire 9 [PHQ-9] scores. Intervention effects on patient outcome variables were tested using intention-to-treat analyses with multilevel models; patient-level covariates of age, sex, baseline depression severity, baseline opioid status (yes/no), and medical morbidity were included. To quantify provider adherence to pain treatment guidelines, we created the Pain Process Measure (PPM), a chart review checklist. Clinicians completed a baseline 23-item survey of attitudes and behaviors related to chronic pain management, job satisfaction, and satisfaction with local pain resources. Patient satisfaction measures included patient-rated global impression of change, global VA health care satisfaction, health-related quality of life, and receipt and rating of effectiveness of VA chronic pain treatment. Pain disability-free days were calculated from Roland-Morris Disability Questionnaire scores. Data on VA treatment costs were obtained from the VA's Decision Support System for all utilization except certain intervention activities that were tracked in a separate study database.

Status:

Complete.

Study Design

Study Type:
Interventional
Actual Enrollment :
401 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Improving the Treatment of Chronic Pain in Primary Care
Study Start Date :
Jan 1, 2006
Actual Primary Completion Date :
Jan 1, 2009
Actual Study Completion Date :
Jul 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: Assistance with Pain Treatment

Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers

Behavioral: Assistance with Pain treatment
Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers. Intervention delivered for 12 months.

No Intervention: Treatment as usual

Treatment as usual

Outcome Measures

Primary Outcome Measures

  1. Adjusted Change in Pain-related Function (Roland Disability Score) [12 months]

    The Roland Morris Disability Questionnaire has 24 yes or no items. Each item is scored as 0 or 1. Item scores or summed to create total score with range 0 to 24. Higher scores represent greater disability. The Roland Morris has been widely used, has content and construct validity, internal consistency, and responsiveness to change among patients with chronic pain.

Secondary Outcome Measures

  1. Adjusted Change in Depression Severity [12 months]

    Patient Health Questionnaire-9 depression rating scale. Range 0-27 with higher scores representing higher depression severity

  2. Adjusted Change in Pain Interference [12 month]

    Chronic Pain Grade interference score. Range 0 to 100 with higher scores representing greater pain interference (worse outcome)

  3. Global Impression of Change [12 months]

    Global impression of change score. Rated at 12 months capturing patient impression of change over past 6 months. Range 1-7 with lower scores representing greater improvement

  4. Adjusted Change in Health Related Quality of Life [12 months]

    EQ-5D. Range 3-15 with higher scores representing worse health states

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients currently receiving primary care at Portland VAMC

  • Diagnosed musculoskeletal chronic pain condition lasting at least 3 months

  • Currently experiencing moderate to severe symptoms as per screening

  • Willingness to complete 6 and 12 month interviews

  • Regular access to a telephone

Exclusion Criteria:
  • Dementia or cognitive disturbance

  • Diagnoses of fibromyalgia, chronic fatigue or somatization disorder Terminal illness

  • Designated guardian

  • Drug-seeking behavior flag in medical record

Contacts and Locations

Locations

Site City State Country Postal Code
1 VA Portland Health Care System, Portland, OR Portland Oregon United States 97239

Sponsors and Collaborators

  • VA Office of Research and Development

Investigators

  • Principal Investigator: Steven K. Dobscha, MD, VA Portland Health Care System, Portland, OR

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT00129480
Other Study ID Numbers:
  • PMI 03-195
First Posted:
Aug 11, 2005
Last Update Posted:
Apr 23, 2019
Last Verified:
Jan 1, 2019

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Assistance With Pain Treatment Treatment as Usual
Arm/Group Description Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers Assistance with Pain treatment: Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers. Intervention delivered for 12 months. Pain treatment as usual
Period Title: Overall Study
STARTED 187 214
COMPLETED 187 214
NOT COMPLETED 0 0

Baseline Characteristics

Arm/Group Title Assistance With Pain Treatment Treatment as Usual Total
Arm/Group Description Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers Assistance with Pain treatment: Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers. Intervention delivered for 12 months. Treatment as usual which includes standard pain care, clinician generated referrals for additional consultation and ancillary services Total of all reporting groups
Overall Participants 187 214 401
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
61.3
(12.3)
62.1
(11.2)
61.7
(11.8)
Sex: Female, Male (Count of Participants)
Female
15
8%
18
8.4%
33
8.2%
Male
172
92%
196
91.6%
368
91.8%
Race/Ethnicity, Customized (Count of Participants)
White
168
89.8%
189
88.3%
357
89%
Black
2
1.1%
5
2.3%
7
1.7%
American Indian/Alaska Native
7
3.7%
6
2.8%
13
3.2%
Unknown
10
5.3%
14
6.5%
24
6%
Region of Enrollment (Count of Participants)
United States
187
100%
214
100%
401
100%

Outcome Measures

1. Primary Outcome
Title Adjusted Change in Pain-related Function (Roland Disability Score)
Description The Roland Morris Disability Questionnaire has 24 yes or no items. Each item is scored as 0 or 1. Item scores or summed to create total score with range 0 to 24. Higher scores represent greater disability. The Roland Morris has been widely used, has content and construct validity, internal consistency, and responsiveness to change among patients with chronic pain.
Time Frame 12 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Assistance With Pain Treatment (Intervention) Treatment as Usual
Arm/Group Description Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers Assistance with Pain treatment: Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers. Intervention delivered for 12 months. Pain treatment as usual
Measure Participants 187 214
Mean (95% Confidence Interval) [units on a scale]
-1.4
-0.2
2. Secondary Outcome
Title Adjusted Change in Depression Severity
Description Patient Health Questionnaire-9 depression rating scale. Range 0-27 with higher scores representing higher depression severity
Time Frame 12 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Assistance With Pain Treatment (Intervention) Treatment as Usual
Arm/Group Description Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers Assistance with Pain treatment: Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers. Intervention delivered for 12 months. Pain treatment as usual
Measure Participants 187 214
Mean (95% Confidence Interval) [units on a scale]
-3.7
-1.2
3. Secondary Outcome
Title Adjusted Change in Pain Interference
Description Chronic Pain Grade interference score. Range 0 to 100 with higher scores representing greater pain interference (worse outcome)
Time Frame 12 month

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Assistance With Pain Treatment (Intervention) Treatment as Usual
Arm/Group Description Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers Assistance with Pain treatment: Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers. Intervention delivered for 12 months. Pain treatment as usual
Measure Participants 187 214
Mean (95% Confidence Interval) [units on a scale]
-5.7
2.3
4. Secondary Outcome
Title Global Impression of Change
Description Global impression of change score. Rated at 12 months capturing patient impression of change over past 6 months. Range 1-7 with lower scores representing greater improvement
Time Frame 12 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Assistance With Pain Treatment (Intervention) Treatment as Usual
Arm/Group Description Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers Assistance with Pain treatment: Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers. Intervention delivered for 12 months. Pain treatment as usual
Measure Participants 187 214
Mean (95% Confidence Interval) [units on a scale]
3.7
4.4
5. Secondary Outcome
Title Adjusted Change in Health Related Quality of Life
Description EQ-5D. Range 3-15 with higher scores representing worse health states
Time Frame 12 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Assistance With Pain Treatment (Intervention) Treatment as Usual
Arm/Group Description Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers Assistance with Pain treatment: Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers. Intervention delivered for 12 months. Pain treatment as usual
Measure Participants 187 214
Mean (95% Confidence Interval) [units on a scale]
-0.02
-0.04

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title Assistance With Pain Treatment Treatment as Usual
Arm/Group Description Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers Assistance with Pain treatment: Care management intervention including assessment, decision support, patient activation, education and followup, provider education, feedback to providers. Intervention delivered for 12 months. Treatment as usual, which includes standard pain care, clinician-generated referrals for additional consultation and ancillary services
All Cause Mortality
Assistance With Pain Treatment Treatment as Usual
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
Assistance With Pain Treatment Treatment as Usual
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/187 (0%) 0/214 (0%)
Other (Not Including Serious) Adverse Events
Assistance With Pain Treatment Treatment as Usual
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/187 (0%) 0/214 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Steven K. Dobscha MD
Organization Portland VA Medical Center
Phone 503-220-8262 ext 52207
Email steven.dobscha@va.gov
Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT00129480
Other Study ID Numbers:
  • PMI 03-195
First Posted:
Aug 11, 2005
Last Update Posted:
Apr 23, 2019
Last Verified:
Jan 1, 2019